Exicure XCUR has been on fire lately, up almost 50% in 5 days.
Exicure XCUR has been on fire lately, up almost 50% in 5 days after a massive amount of volume being injected into this little well known stock. The stock has been crashing for the last 6 months. I have written a full report on XCUR that you can read below.
However, before you read this insightful information, sign up below, let’s stay in contact.
Exicure XCUR has some very bad press, check it out “UPCOMING DEADLINE ALERT: The Schall Law Firm Encourages Investors in Exicure, Inc. with Losses of $100,000 to Contact the Firm” Before we get started, let’s review some basic information on this company.
Exicure XCUR Company Summary
Company Name: LimitExicure
Ticker: XCUR
Exchange: NASDAQ
Exicure, Inc. Company Summary
Exicure, Inc. is a development-stage biotechnology company developing therapeutics for neurology and rare genetic disorders based on its proprietary spherical nucleic acid (SNA™) technology. Exicure’s proprietary SNA architecture is designed to unlock the potential of therapeutic oligonucleotides in a wide range of cells and tissues. Exicure’s lead programs address neuroscience diseases and genetic disorders. Exicure is based in Chicago, IL.
SNA constructs overcome one of the most difficult obstacles to nucleic acid therapeutics: safe and effective delivery into cells and tissues. SNA constructs exhibit unparalleled transfection efficiency into numerous cell and tissue types, including the skin, without carriers or transfection agents.
SNA™ technology originated in the lab of Professor Chad A. Mirkin at the Northwestern University International Institute for Nanotechnology.
XCUR News
NEW YORK, NY / ACCESSWIRE / December 16, 2021 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Exicure, Inc. (“Exicure” or the “Company”) (NASDAQ:XCUR) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Exicure securities between March 11, 2021 and November 15, 2021, inclusive (the “Class Period”).
XCUR 1 Month Chart
XCUR Technical Analysis
Why stocks go up baffles me, but this one has broken two resistance points and looks strong and BULLISH. I think its worth putting on your watchlist.
Remember, to never try and catch a falling safe, or a knife for that matter. Simply let it fall to the ground, walk over, and pick up the money and walk away. If you enjoyed this article, sign up below, I promise I will never spam you and I’m pretty darn good at picking winners. Let’s make some trades together!
ProQR Therapeutics PRQR looking to bounce, like a basketball?
ProQR Therapeutics PRQR is up over 15% after due to a massive amount of volume being injected into this stock that has been crashing for the last few months. I have written a full report on PRQR that you can read below.
However, before you read this insightful information, sign up below, let’s stay in contact.
ProQR Therapeutics PRQR Company Summary
Company Name: ProQR Therapeutics N.V.
Ticker: PRQR
Exchange: NASDAQ
Website: www.proqr.com.
ProQR Therapeutics N.V. Company Summary
ProQR Therapeutics is dedicated to changing lives through the creation of transformative RNA therapies for the treatment of severe genetic rare diseases such as Leber congenital amaurosis 10, Usher syndrome and retinitis pigmentosa. Based on our unique proprietary RNA repair platform technologies we are growing our pipeline with patients and loved ones in mind.
LVGI News
Jan. 04, 2022
Announced that the last patient completed their last visit (Month 12) in the Phase 2/3 Illuminate trial of sepofarsen for CEP290-mediated Leber Congenital Amaurosis 10 (LCA10) due to the p.Cys998X mutation, also known as c.2991+1655A>G.
LVGI 1 Month Chart
PRQR Technical Analysis
The stock is looking solid on the 5 day and has broke through resistance. It has officially reversed it’s trend, I like it!
Remember, to never try and catch a falling safe, or a knife for that matter. Simply let it fall to the ground, walk over, and pick up the money and walk away. If you enjoyed this article, sign up below, I promise I will never spam you and I’m pretty darn good at picking winners. Let’s make some trades together!
Robinhood Markets HOOD official trend reversal, take a look!
Robinhood Markets HOOD is up almost 30% after great 4th QTR earning news and due to a massive amount of volume being injected into this trading platform that has been crashing since August. I have written a full report on HOOD that you can read below.
However, before you read this insightful information, sign up below, let’s stay in contact.
Robinhood announced today, “Total net revenues for the quarter increased 14% to $363 million, compared with $318 million in the fourth quarter of 2020, and for the year increased 89% to $1.82 billion, compared with $959 million for the year ended December 31, 2020.” However, before we get started, let’s review some basic information on this company.
Robinhood Markets HOOD Company Summary
Company Name: Robinhood Markets, Inc
Ticker: HOOD
Exchange: NASDAQ
Website: https://robinhood.com/
Robinhood Markets, Inc Company Summary
Robinhood Markets is on a mission to democratize finance for all. With Robinhood, people can invest with no account minimums through Robinhood Financial, LLC, buy and sell crypto through Robinhood Crypto, LLC, and learn about investing through easy-to-understand educational content.
Robinhood intends to use its blog, Under the Hood, as a means of disclosing material information to the public in a broad, non-exclusionary manner for purposes of the SEC’s Regulation Fair Disclosure (Reg. FD). Under the Hood can be accessed at blog.robinhood.com and investors should routinely monitor that website, in addition to Robinhood’s press releases, SEC filings, and public conference calls and webcasts, as information posted on Robinhood’s blog could be deemed to be material information.
“Robinhood” and the Robinhood feather logo are registered trademarks of Robinhood Markets, Inc. All other names are trademarks and/or registered trademarks of their respective owners.
HOOD News
Jan 27th, 2022
Total net revenues for the quarter increased 14% to $363 million, compared with $318 million in the fourth quarter of 2020, and for the year increased 89% to $1.82 billion, compared with $959 million for the year ended December 31, 2020.
Dec. 31, 2021
Wolf Haldenstein Adler Freeman & Herz LLP announces that a federal securities class action lawsuit has been filed in the United States District Court for the Northern District of California on behalf of investors who purchased or otherwise acquired Robinhood Markets, Inc. (“Robinhood” or the “Company”) (NASDAQ: HOOD) common stock pursuant and/or traceable to the Registration Statement issued in connection with the Company’s July 2021 initial public offering (the “IPO” or “Offering”).
HOOD 3 Month Chart
HOOD Technical Analysis
The news of the class action lawsuit has sent HOOD tumbling. Could the financials reverse it’s trend?
The answer is yes, it has from a technical analysis. HOOD has broken through resistance #1 and resistance #2. WOW, this could take off. Remember it was trading at $70 not too long ago.
Remember, to never try and catch a falling safe, or a knife for that matter. Simply let it fall to the ground, walk over, and pick up the money and walk away. If you enjoyed this article, sign up below, I promise I will never spam you and I’m pretty darn good at picking winners. Let’s make some trades together!